Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity
使用 CD47/PD-L1 双特异性抗体选择性阻断 CD47 信号以增强抗肿瘤活性并限制毒性
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-020-02679-5
Yan Wang, Haiqing Ni, Shuaixiang Zhou, Kaijie He, Yarong Gao, Weiwei Wu, Min Wu, Zhihai Wu, Xuan Qiu, Ying Zhou, Bingliang Chen, Donghui Pan, Chenrong Huang, Mingzhu Li, Yicong Bian, Min Yang, Liyan Miao, Junjian Liu